Connor, Clark & Lunn Investment Management Ltd. Incyte Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.1 Billion
- Q1 2025
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Incyte Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 533,717 shares of INCY stock, worth $37.3 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
533,717
Previous 704,085
24.2%
Holding current value
$37.3 Million
Previous $48.6 Million
33.55%
% of portfolio
0.15%
Previous 0.24%
Shares
31 transactions
Others Institutions Holding INCY
# of Institutions
695Shares Held
194MCall Options Held
564KPut Options Held
331K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.15 Billion22.18% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.49 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20MShares$1.4 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.9MShares$1.04 Billion0.55% of portfolio
-
State Street Corp Boston, MA10MShares$701 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $15.5B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...